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Abstract 
Distribution and regulation of androgen receptor expression during fetal and neonatal virilization of the rat fetus was 
assessed by immunohistochemistry. In mesonephric duct derivatives the androgen receptor expression became evident first in 
the efferent ductules and epididymis (on fetal day 14), subsequently in the vas deferens and finally in the seminal vesicle. 
Mesenchymal cells of the urogenital tubercle were positive for androgen receptors from fetal day 14 onwards. In the 
mesenchymal cells of the prostate anlagen, androgen receptor positive cells were found first on fetal day 16. Administration of 
5cY-dihydrotestosterone to pregnant rats from day 11 to day 20 of gestation caused a stabilization of the wolffian duct in female 
fetuses. The androgen receptor expression pattern became similar as found in male fetuses, and showed an increase in density 
and in frequency of androgen receptor positive cells. Administration of the androgen antagonist flutamide during the same 
interval caused a reduction in density and frequency of androgen receptor positive cells in male fetuses. These findings 
indicate that androgens enhance the expression of androgen receptors in the developing rat genital tract by induction of 
androgen receptor positive cells, and by increasing the frequency. The developmental pattern of androgen receptor expression 
in the rat mesonephric duct system reflects the androgen-responsiveness of the ducts, and is consistent with induction of the 
androgen receptor along the ducts by testosterone reaching these structures in an exocrine fashion. 
Keywords: Receptor; Androgen; Fetus; Rat 
1. Introduction 
Normal development and functioning of male geni- 
talia are primarily controlled by androgens (Wilson et 
al., 1981). In most androgen target cells testosterone 
is converted into its metabolite 5a-dihydro- 
testosterone. Testosterone and 5cr-dihydro- 
testosterone play separate roles in fetal male differ- 
entiation: testosterone mediates wolffian duct viriliza- 
tion, while differentiation of the urogenital sinus and 
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the external genitalia depends upon 5c~-dihydro- 
testosterone (Griffin and Wilson, 1989). The different 
roles of the two hormones is clearly reflected in the 
5cu-reductase type 2 deficiency syndrome. In individu- 
als with this syndrome masculinization of the urogeni- 
tal sinus and external genitalia does not occur during 
fetal life, but wolffian duct development proceeds into 
epididymis, vas deferens and seminal vesicle. Com- 
pelling evidence exists that both testosterone and 
5cr-dihydrotestosterone act via the same receptor pro- 
tein, because in individuals with the complete form of 
androgen insensitivity the wolffian duct stabilization, 
as well as virilization of the urogenital sinus and 
tubercle, are affected (Griffin and Wilson, 1989). 
0303-7207/95/%09.50 0 1995 Elsevier Science Ireland Ltd. Ah rights reserved. 
SSDI 0303-7207(95)03593-V 
246 F. M. Bentvelsen et al. /Molecular and Cellular Endocrinology 1 I3 (1995) 245-253 
Differentiation of the wolffian ducts into male in- 
ternal genitalia begins at week 8 of gestation in man, 
and at fetal day 14 in the rat (Price and Ortiz, 1965). 
During early development of male genitalia the dis- 
tribution of AR differs from that of later stages in 
that AR expression initially is present only in mes- 
enchymal cells and later also appears in the epithe- 
lium (Cooke et al., 1991). Androgens induce epithelial 
differentiation of the genitalia via action in mesenchy- 
ma1 cells (Shannon and Cunha, 1983; Takeda et al., 
1985). 
In earlier work we have demonstrated that during 
early sexual differentiation in the male and female rat 
fetus ARs are present at equally high levels in the 
urogenital tubercle and sinus of both sexes (Bentvel- 
sen et al., 1994). In the tubercle of male fetuses AR 
expression increases with time, while in female fe- 
tuses AR protein expression of the tubercle dimin- 
ishes. Those immunoblotting studies, however, were 
by no means conclusive with respect to the cellular 
distribution of the AR, either these changes are 
caused by alterations in the cellular density of AR 
expression or in the frequency of AR positive cells. 
Studies on the cellular distribution of AR expression 
in the developing urogenital tract are based on au- 
toradiography (Shannon and Cunha, 1983; Takeda et 
al., 1985; Cooke et al., 1991). In autoradiographic 
studies, however, radioactivity is detected, not only of 
the primary label, but also including the metabolites 
of androgens that might have binding characteristics 
different from the primary label. In the cells which 
are negative in the autoradiograms, occupancy of the 
AR by endogenous unlabelled ligand cannot be ex- 
cluded. This consequently results in a false negative 
signal. 
Since a sensitive specific immunohistochemical s- 
say for paraffin-embedded tissues was developed re- 
cently (Janssen et al., 1994), we have used this assay 
to re-examine the developmental pattern of the dif- 
ferential expression of the AR at the protein level. 
Our observations indicate that androgens enhance 
the expression of AR in developing rat genital tract 
by increasing the density and frequency of AR posi- 
tive cells. 
2. Materials and methods 
2.1, Animals 
Wistar rats (obtained from TNO, Rijswijk, The 
Netherlands) were maintained under controlled con- 
ditions of day and night (14 and 10 h, respectively) 
and temperature (20 f 1“C) and allowed free access 
to standard laboratory chow and tap water. Timed 
pregnant dams (vaginal plug = day 0; term = day 
22) were killed at the start of sexual differentiation of 
the mesonephric ducts on day 14, and further on days 
16, 18,20 and 21 of pregnancy. Fetuses were removed 
immediately. Newborn rats were sacrificed on days 2, 
5 and 10. Flutamide (a kind gift from Schering Corp., 
Bloomfield, NJ) was administrated 100 mg/kg body 
weight per day, and 5cu-dihydrotestosterone (DHT) 50 
mg/kg body weight per day. Both drugs were dis- 
solved in 10% ethanol/90% olive oil and were admin- 
istered daily by subcutaneous injection from day 11 to 
day 20 of gestation. The treated fetuses were killed on 
day 21. 
Fetuses and neonates were fixed in 10% neutral 
phosphate-buffered formalin. After 24 h the bodies 
were cut into two halves. Sex was confirmed by go- 
nadal inspection. From each age, two to four animals 
were analyzed. The lower body halves (without in- 
testines, extremities and tail) were embedded in 
paraffin. 
2.2. Antiserum against AR 
The antiserum used was raised in rabbits against a 
synthetic peptide identical to the first 20 amino acid 
residues of the N-terminal domain of the human and 
rat AR. The polyclonal antibodies were developed as 
previously described (Zegers et al., 1991). The 
oligopeptides were conjugated to keyhole limpet 
hemocyanin (KLH, Calbiochem, San Diego, CA) for 
immunization of rabbits (Flemish Giant random bred, 
MBL-TNO, Rijswijk, The Netherlands). The sera were 
tested in a direct ELISA for antipeptide response, 
and in an immunoprecipitation assay for AR specific- 
ity. The antibodies will be referred to as SP197 (Jans- 
sen et al., in preparation). 
2.3. Immunohistochemistry 
Details for immunohistochemical procedures have 
been reported previously (Janssen et al., 1994). All 
sections (5 pm) were cut transversely and mounted 
on slides coated with 3-aminopropyl triethoq-silane 
(Sigma Chemical Co., S. Louis, MO). Slides were 
dried overnight at 60°C dewaxed and rehydrated, 
after endogenous peroxidase activity was blocked with 
3% H,O, in methanol. Sections were then mi- 
crowaved three times for 5 min at 700 W under 0.01 
M citric acid monohydrate buffer (pH 6.0), after which 
they were cooled to room temperature and rinsed 
with PBS (pH 7.4). The sections were pre-incubated 
with 10% normal goat serum (Dako, Glostrup, Den- 
mark) in PBS for 15 min. Then sections were in- 
cubated overnight at 4°C with the primary antibodies 
SP197. The immune serum SP197 was diluted 1:8000 
in PBS (vol/vol). Control sections were incubated 
either with nonimmune rabbit serum, diluted to the 
same extent as the primary antibodies, or with the 
primary antibodies, after incubation of the antibodies 
overnight with an excess of the free peptide (1 mg/ml), 
which was used to raise the antibodies. The anti- 
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bodies and peptide were diluted to 19000 in PBS intensively at fetal day 18 (Fig. 2b). At this stage, a 
(vol/vol) for bl oc ‘ng experiments. Staining was car- lu higher frequency of cells of the urothelium expressing 
ried out by the avidin-biotin peroxidase method. Cells the AR was observed. On day 2 a few epithelial cells 
were considered AR positive, when a nuclear staining of the prostate showed weak AR staining. The ma- 
was observed. Nuclear counterstaining was performed jority of epithelial cells of the prostate was AR + on 
with Mayer’s hematoxylin. day 5 after birth (Fig. 2~). 
3. Results 
3.1. Immunohistochemistry 
Efferent ductules. Day 14 is the onset of sexual 
differentiation of the efferent ductules and wolffian 
duct in the rat fetus. The efferent ductules contained 
some AR + mesenchymal cells on day 14 (Fig. la>. At 
this age the efferent ductules were the first sites of 
the mesonephric duct system in which AR expression 
also occurred in epithelial cells. Preincubation of the 
antibodies with the corresponding peptide blocked 
the nuclear staining pattern (Fig. lc>. During the 
whole further period of gestation from day 14 to day 
10 after birth both epithelium and mesenchyme of the 
efferent ductules were AR + . 
Urogenital tubercle, fords and swellings. The mes- 
enchymal cells of the urogenital tubercle. of the geni- 
tal folds and of the genital swellings, respectively, 
were positive for AR from fetal day 14 onwards (Fig. 
2d). During development of the external genitalia the 
amount of mesenchymal cells expressing the AR in- 
creased progressively (Fig. 2e,f). The epithelial cells in 
the skin of the tubercle showed AR expression from 
day 5 after birth. 
3.2. Differential AR expression pattern in the urogenital 
tract compared with some other androgen-dependent 
developmental structures: mammary gland, 
gubemaculum and perineum 
Wolfian duct. The mesenchyme around the wolf- 
fian duct exhibited nuclear staining on day 14 (Fig. 
la,b). At the medial side of the wolffian duct more 
mesenchymal cells showed AR + than at the lateral 
side, close to the miillerian duct (n = 4). The epithe- 
lia of the wolffian duct and the miillerian duct were 
negative at days 14 and 16. At day 18 of gestation, 
epithelial cells of the epididymal head stained for AR 
(Fig. Id). The epididymal tail showed mesenchymal 
cells expressing the AR from day 18 of gestation (Fig. 
le), but epithelium remained negative. Epithelial cells 
of the epididymal tail were weakly AR + at day 2 
after birth. At days 5 and 10 the proportion of epithe- 
lial AR + cells was increased (Fig. If) as compared to 
day 2. 
Nipple primordia of mammary gland. In the nipple 
anlagen of the mammary gland many AR + mes- 
enchymal cells were found on fetal day 14 (Fig. 3a). 
Gubemaculum. At fetal day 18, the mesenchyme of 
the gubernacular cone showed AR + cells, particu- 
larly in the core (Fig. 3b). Some positive cells were 
identified in the gubernacular ligament or cord (Figs. 
3b and le). 
Perineum and prepubic region. An abundant amount 
of mesenchymal AR + cells was noticed in the per- 
ineum from day 18 onwards (3c), and also in the 
prepubic region (not shown). 
In the vas deferens (distal wolffian duct) the AR 
was not detectable on days 14, 16 and 18, but became 
weakly detectable in the mesenchyme on fetal day 20 
and in the epithelium from day 2 postnatally. On day 
5, the epithelium of the vas deferens contained exclu- 
sively positive cells surrounded by a ring of AR-nega- 
tive tissue: the basal cell layer (Fig. If). This basal cell 
layer was surrounded by a ring of AR + mesenchymal 
cells. The seminal vesicles exhibited AR + cells in the 
mesenchyme from fetal day 21 onwards, and in the 
epithelium from day 2 after birth (Fig. 2~). 
Female urogenital tissues. Miillerian duct structures 
remained negative for AR at all examined ages in 
male and female fetuses. In female fetuses at fetal 
days 18 and 21, AR expression in the regressing 
wolffian duct (Fig. 3d), urogenital sinus (Fig. 3e) and 
tubercle (Fig. 3f), respectively, was low compared to 
frequencies of AR + cells observed in male fetuses. 
3.3. Effect of DHT or putamide on AR expression in 
genital tracts of female and male rat fetuses, respective& 
Wolfian duct. Administration of 5 cY-dihydro- 
testosterone from days 11 to 20 of gestation to preg- 
nant rats caused a stabilization of the wolffian duct in 
female fetuses with an androgen receptor expression 
pattern similar to that found in male fetuses (Fig. 4a). 
Urogenital sinus. On fetal day 14 the prostate anla- 
gen did not show the AR, but some staining of cells in 
the urothelium on top of the verumontanum was 
found, at the site where the ejaculatory ducts enter 
the sinus (Fig. 2a). On fetal day 16 AR + cells were 
found only in the mesenchymal part of the prostate 
anlagen. The mesenchyme of the prostate stained 
No AR was detectable in the mesenchyme around 
the wolffian duct from the male fetus on fetal day 21, 
after exposure to flutamide given daily starting from 
fetal day 11 (Fig. 4b). 
Urogenital sinus. High AR levels in the mes- 
enchyrne of the prostate anlagen in female fetuses 
after DHT were consistent with a masculine pattern 
of differentiation of the prostate anlagen (Fig. 4~). 
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In the flutamide-treated male fetus, AR expression tamide in male fetuses caused a reduction in AR + 
was diminished and prostate development was re- cells and an underdevelopment of the urogenital tu- 
tarded (Fig. 4d). bercle with a wide open urethra (Fig. 4f). 
Urogenital tubercle. In the female fetus, DHT 
administration caused an outgrowth of the tubercle 
which differentiated into the male direction, and an 
increase in cells positive for AR (Fig. 4e). 
Administration of the androgen antagonist flu- 
4. Discussion 
This study provides in vivo evidence that expression 
of the androgen receptor (AR) is regulated by andro- 
d 
e 
Fig. 1. Immunohistochemical staining of the androgen receptor in the wolffian duct. (a,b,c) Wolffian duct (WD), efferent ductules (ED) and 
milllerian duct (MD) are shown at fetal day 14. (cl The specificity of the immunoreactivity was indicated by the lack of nuclear staining after 
preincubation of the antibodies with the peptide SP197. (d) The epididymal head (EH) at fetal day 18, TE is testis. (e) The epididymis tail (ET) 
and the gubemacular ligament (GL), the vas deferens (VD) and the bladder (BL) at day 18. (f) The vas deferens and epididymal tail (neonatal 
day 5). Bar = 25 pm in a,b,c; bar = 50 pm in d,e,f. 
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Fig. 2. Immunohistochemical staining of the androgen receptor in the genital tubercle, sinus and surrounding tissues in the male rat. (a) The 
urogenital sinus WS), the prostate anlagen (PA) and the verumontanum (VE) on fetal day 14 at the location, where the ejaculatory ducts (El) 
enter the sinus. (b> fetal day 18. (c) Budding of the prostate at postnatal day 5; SV are seminal vesicles. (d,e,D The urogenital tubercle (GT) 
with urethra (UR), genital fold (GF) and swelling (GS). (d) day 14; (e) day 18; (fl2 days after birth. Bar = 50 pm in a,b,c; bar = 100 pm in 
d,e,f. 
gens during morphogenesis of the genitalia. The AR 
is first induced in the mesenchymal cells and subse- 
quently in the epithelial cells. The sequential appear- 
ante of the AR in mesenchymal and in epithelial cells 
in fetal and neonatal male reproductive tissues is 
given in a timetable (Table 1). At fetal day 14 (the 
first day of investigation) only the efferent ductules 
showed some AR-positive epithelial cells as well as 
AR-positive mesenchymal cells. In other tissues, we 
found AR expression in the mesenchyme before the 
epithelium became positive. 
From studies of the 5cy-reductase type 2 deficiency 
syndrome (Wilson et al., 1981) it is clear that the 
efferent ductules and the wolffian duct are stabilized 
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Fig. 3. Immunohistochemical staining of the androgen receptor in the nipple anlagen, in the gubemaculum and in the perineum of the male 
fetus, and in the miillerian and wolffian ducts, in the genital sinus and in the tubercle of the female fetus. (a) Day 14: the nipple anlagen (NP). 
(b) Day 18): the gubemacular cone (GC) and part of the ligament (GL). (c) Perineum (PE) at fetal day 18. The midline (ML) between the 
urethra and the skin is indicated. (d) Day 18: the miilierian duct (MD), the wolffian duct (WD) regresses. (e) Day 18: the female urogenital 
sinus. (f) Day 18: the female urogenital tubercle (GT), genital fold (GF) and swelling (GS). Bar = 25 grn in a,d,e; bar = 50 pm in c; bar = 
100 pm in b,f. 
by testosterone. Probably, testosterone interacts with 
these tissues in an ‘exocrine’ fashion: high concentra- 
tions of testosterone diffuse from the testis via the 
efferent ductules down the lumen of the wolffian 
duct, creating a testosterone gradient along the wolf- 
fian duct (Veyssiere, 1982). This concept is supported 
by a recent study in which transport of fluorescence- 
labelled testosterone down the wolffian duct was re- 
ported during sexual differentiation of the mouse 
(Tong and Hutson, 1994). 
Sinke testosterone (and not 5 cY-dihydro- 
testosterone) virilizes efferent ductules and wolffian 
duct, it is conceivable that testosterone stabilizes the 
efferent ductules and the upper part the epididymis, 
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Fig. 4. Effect of 5a-dihydrotestosterone on the urogenital tract in the female rat on fetal day 21, and the effect of the anti-androgen flutamide 
on the genitalia in the male fetus of the same age. (a) Wolffian duct (WD) and the efferent ductules (ED) were present in the female (MD: 
miillerian duct, OV: ovary). (b) Wolffian duct after exposure to flutamide in the male. Cc) Prostate anlagen (PA) ventral of the urogenital sinus 
(US) in the female fetuses treated with DHT. Cd) Differentiation of the prostate anlagen (PA) was retarded in the flutamide treated male 
fetuses. (e) The virilized female genital tubercle (GT) and genital fold (GF). (f) Underdevelopment of the male genital tubercle with a cleft 
urethra (UR). Bar = 50 pm in a,b,c,d; bar = 100 km in e,f. 
followed by the remaining part of the epididymis, the 
vas deferens and finally the seminal vesicle. In some 
species, however, the distal part and, to a smaller 
extent, the middle part of the wolffian duct may be 
less dependent on virilization by testosterone (Tsju et 
al., 1994). Relatively high levels of testosterone reach 
these tissues by diffusion through the lumen of the 
mesonephric duct system, increasing AR expression in 
the efferent ductules and the medial side of the 
wolffian duct close to the testis, respectively, followed 
by the remaining part of the wolffian duct: the epi- 
didymis and, later in fetal life, the vas deferens and 
seminal vesicle. The higher content of androgen re- 
ceptor observed at the medial part of the wolffian 
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Table 1 
AR expression in mesenchymal nd epithelial cells during development of fetal and neonatal male genitalia. 
Tissue: 
Efferent ductules 
Epididymis (head) 
Epididymis (tail) 
Vas deferens 
Seminal vesicle 
Prostate anlagen 
Tubercle 
Gubemaculum 
14 15 16 17 18 19 20 21 0 1 2 3 4 5 6 7 8 9 10 
Neonatal t Neonatal 
Birth 
Age (days) 
mesenchyme AR + ( --); both mesenchyme and epithelium AR + ( = ). 
duct in comparison to the lateral side may reflect a 
higher testosterone gradient caused by the hormonal 
diffusion from the testis. Prevention of transport of 
testosterone through the mesonephric duct deriva- 
tives may affect AR expression in the target cells 
negatively. Consequently androgen-dependent devel- 
opment may be inhibited, which results in degenera- 
tion of the vas deferens. According to this hypothesis, 
mechanical obstruction of hormonal transport in the 
epididymis could explain the congenital absence of 
the vas deferens as found in patients with cystic 
fibrosis (Tizzano et al., 1994). 
Various modulating physiological effects of andro- 
gens during embryogenesis are mediated by AR ex- 
pressed in the mesenchymal cells. For example, 
male-type differential growth of the urogenital tuber- 
cle stimulated by androgen action starts with an abun- 
dant AR-positive mesenchyme (Shannon and Cunha, 
1983; Takeda et al., 1985; Husmann et al., 19901, 
while the effect of androgen action in the nipple 
primordia of the mammary gland in the male rat 
implies the ultimate regression of the nipple primor- 
dia (Wasner et al., 1983). The androgen-induced 
elimination is induced by androgen-activated mes- 
enchymal cells, since the mesenchyme contained many 
AR-positive cells in contrast to the negative epithe- 
lium. 
During the investigated period, the genital tubercle 
showed an increasing proportion of cells expressing 
AR in the mesenchymal cells. Five days postnatally, 
AR-expressing epithelial cells were noticed in the 
prepuce. The AR expression of the rat penis during 
maturation has been studied extensively previously 
(Gonzales-Cadavid et al., 1991; Takane et al., 1991). 
After sexual maturation, AR staining is only present 
in epithelial nuclei of preputial skin and urethra. 
The presence of large amounts of AR in the per- 
ineum suggests a role for androgens in perineal out- 
growth. During sexual differentiation the rat penis 
migrates to a more ventral position than the female 
tubercle. George (1989) showed, that exposure of 
male rat fetuses to a 5c~-reductase inhibitor during 
sexual differentiation reduced the distance between 
the anus and tubercle, indicating that this process is 
highly &dihydrotestosterone dependent. Further- 
more, in this caudal region in the rat, androgen action 
is reflected in the sexual dimorphism in the levator 
ani/bulbocavemosus muscle group (Jung and Baulieu, 
1972). 
The role of androgen action in testicular descent is 
still under debate (Van der Schoot, 1992). Our study 
confirms the presence of AR in the rat gubemaculum 
(Husmann and McPhaul, 1991; Bentvelsen and 
George, 1993). AR-positive cells are present in the 
gubernacular cord (or ligament) and in the core of the 
gubernacular cone, before inversion of the cone into 
a cremaster sac. 
In the female genital tract AR does not seem to 
play a significant role. The protein disappears when 
the indifferent sexual stage has changed into a female 
direction. These data coincide with the observation 
that the critical period of AR action on the develop- 
ing genitalia ends soon after birth (Schultz and Wilson, 
1974). The decrease in the amount of AR-positive 
cells in female fetuses could be prevented by adminis- 
tration of DHT to the pregnant dams. Exposure to 
androgen caused a stabilization of the wolffian duct in 
the females. Furthermore, a decrease in the number 
of AR-containing cells in the genital tract of male 
fetuses was seen following the administration of the 
anti-androgen flutamide to pregnant rats. 
In conclusion, these findings demonstrate the AR 
distribution in various tissues of the developing male 
genital tract of the male rat. Our data provide support 
for a mechanism by which androgens modulate the 
expression of AR in the genital tract by induction and 
subsequently proliferation of AR-containing cells. It 
is consistent with the idea that virilization of the 
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efferent ducts and the wolffian duct is accomplished 
by large amounts of testosterone reaching these struc- 
tures in an exocrine fashion. In these tissues, testos- 
terone induces the AR, first in the mesenchyme, and 
subsequently in the epithelium in a temporal fashion. 
The earliest expression is found in tissues with the 
smallest distance to the testis. In tissues virilized by 
5a-dihydrotestosterone in an endocrine way, ARs ap- 
pear later, but also first in the mesenchymal cells, and 
thereafter in the epithelial cells. The factors in the 
mesenchyme mediating the epithelial induction of 
ARs remain to be determined. 
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